Macular oedema in Kawasaki syndrome.
Clinic for Uveitis, Swiss Eye Institute and University of Bern, Bern, Switzerland. justus.garweg@eye-institute.ch
Justus G
JG
Garweg
Claudia
C
Suter
Christine
C
Aebi-Ochsner
Reto
R
Villiger
D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008269:Macular Edema / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D041623:Tomography, Optical Coherence
D005343:Fibrinolytic Agents; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D011239:Prednisolone; D001241:Aspirin